Adelaide tech company achieves $2.3 million in development milestones

Adelaide-based Micro-X has achieved $2.3 million worth of development milestones across three major contracts with international partners, the company announced on Monday.

The hi-tech company achieved Milestone 3 under its Development Agreement with the US Advanced Research Projects Agency for Health for a Full Body CT scanner, delivering $1.4 million.

Micro-X also achieved Milestone 2 under its Strategic Partnership Agreement with Billion Prima for a baggage and parcel scanning unit due for completion in 2025, delivering $900,000.

The company has also delivered and installed the first self-screening checkpoint module at a Department of Homeland Security test laboratory.

All development milestones were achieved on time and in budget, with both projects tracking to plan overall.

Chief Executive Officer Kingsley Hall said: “We are pleased to continue to deliver strong progress on these key development contracts with ARPA-H, DHS, and Billion Prima respectively, which is a testament to our focus and timely delivery on key projects.

“We hosted the Billion Prima team in Tonsley again this week and the relationship between us continues to grow stronger with each visit.”

Micro-X entered a $5.6 million Strategic Partnership arrangement with Billion Prima in February 2025, which included $3.2 million to commercialise a baggage and parcel scanning unit enabled by Micro-X NEX Technology.

Under the arrangement, Billion Prima will receive exclusive rights to manufacture and sell the unit in South-East Asia for 20 years.

The company has progressed on time and in budget with design and architecture work for the lightweight Full Body CT scanner prototype under the ARPA-H Development Contract for US$8.2 million and up to US$16.4 million.

Micro-X continues to progress the DHS project on time and in budget. The company has invoiced DHS $5.6 million thus far in FY25 and has $4.0 million remaining on the committed contract through May 2026.

DHS has an option to extend that contract for a further $7.0 million executable in the second half of FY26.

Hall said the company was well advanced with the final stages of its Head CT development as it prepares to enter human imaging trials.

Micro-X develops and commercialises innovative products for global health and security markets based on proprietary cold cathode, carbon nanotube emitter technology.

Picture: supplied